These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 118929)

  • 1. Alternate complement pathway activation by group A streptococci: role of M-protein.
    Bisno AL
    Infect Immun; 1979 Dec; 26(3):1172-6. PubMed ID: 118929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M proteins of group G streptococci: mechanisms of resistance to phagocytosis.
    Campo RE; Schultz DR; Bisno AL
    J Infect Dis; 1995 Mar; 171(3):601-6. PubMed ID: 7876607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin.
    Beachey EH; Campbell GL; Ofek I
    Infect Immun; 1974 May; 9(5):891-6. PubMed ID: 4132911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
    Hong K; Kinoshita T; Takeda J; Kozono H; Pramoonjago P; Kim YU; Inoue K
    Infect Immun; 1990 Aug; 58(8):2535-41. PubMed ID: 2142480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of M protein in phagocytosis. II. Opsonization of Streptococcus pyogenes in vitro.
    Tylewska S; Hryniewicz W
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):44-7. PubMed ID: 44622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.
    Spitznagel JK; Goodrum KJ; Warejcka DJ; Weaver JL; Miller HL; Babcock L
    Infect Immun; 1986 Jun; 52(3):803-11. PubMed ID: 3086232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.
    Jacks-Weis J; Kim Y; Cleary PP
    J Immunol; 1982 Apr; 128(4):1897-902. PubMed ID: 7037956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.
    Dale JB; Washburn RG; Marques MB; Wessels MR
    Infect Immun; 1996 May; 64(5):1495-501. PubMed ID: 8613352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1.
    Pandiripally V; Gregory E; Cue D
    Infect Immun; 2002 Nov; 70(11):6206-14. PubMed ID: 12379699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of alternative complement pathway opsonization by group A streptococcal M protein.
    Peterson PK; Schmeling D; Cleary PP; Wilkinson BJ; Kim Y; Quie PG
    J Infect Dis; 1979 May; 139(5):575-85. PubMed ID: 374652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin.
    Gemmell CG; Peterson PK; Schmeling D; Kim Y; Mathews J; Wannamaker L; Quie PG
    J Clin Invest; 1981 May; 67(5):1249-56. PubMed ID: 7014632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
    Weis JJ; Law SK; Levine RP; Cleary PP
    J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci.
    Whitnack E; Beachey EH
    J Clin Invest; 1982 Apr; 69(4):1042-5. PubMed ID: 7042754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the alternate complement pathway by peptidoglycan of Actinomyces viscosus, a potentially pathogenic oral bacterium.
    Baker JJ; Billy SA
    Arch Oral Biol; 1983; 28(11):1073-5. PubMed ID: 6362630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen binding inhibits the fixation of the third component of human complement on surface of groups A, B, C, and G streptococci.
    Chhatwal GS; Dutra IS; Blobel H
    Microbiol Immunol; 1985; 29(10):973-80. PubMed ID: 3908887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of complement subcomponent C1q to Streptococcus pyogenes: evidence for interactions with the M5 and FcRA76 proteins.
    Koroleva IV; Sjöholm AG; Schalén C
    FEMS Immunol Med Microbiol; 1998 Jan; 20(1):11-20. PubMed ID: 9514571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M proteins of group G streptococci isolated from bacteremic human infections.
    Bisno AL; Craven DE; McCabe WR
    Infect Immun; 1987 Mar; 55(3):753-7. PubMed ID: 3102380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.
    Horstmann RD; Sievertsen HJ; Knobloch J; Fischetti VA
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1657-61. PubMed ID: 2964038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cell surface antigens of Streptococcus equi.
    Erickson ED; Norcross NL
    Can J Comp Med; 1975 Apr; 39(2):110-5. PubMed ID: 804979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of subinhibitory concentrations of josamycin on the expression of M protein by group A streptococci.
    Lam C; Basalka E
    Eur J Clin Microbiol; 1985 Jun; 4(3):279-81. PubMed ID: 3894016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.